Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
Global Nutrition Target Collaborators None., (2025), Lancet, 404, 2543 - 2583
In CKD, electronic letter nudges for patients or providers did not increase RASi or SGLT2i prescriptions at 6 mo.
Turnbull I. et al, (2025), Ann Intern Med
COVID-19 and anxiety in pregnancy and postpartum: a longitudinal survey
Ayers S. et al, (2025), BMC Public Health, 25
Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies.
Kantor J. et al, (2025), Hum Vaccin Immunother, 21
Flash glucose monitoring for Indigenous Australians with type 2 diabetes: a randomised pilot and feasibility study
Eer AS. et al, (2025), Pilot and Feasibility Studies, 11
Long-term exposure to fine particulate matter interacting with individual conditions increase breast cancer incidence: a large-scale Chinese cohort
Sun Y. et al, (2025), Environmental Sciences Europe, 37
Machine learning derived retinal pigment score from ophthalmic imaging shows ethnicity is not biology
Rajesh AE. et al, (2025), Nature Communications, 16
Self-rated benefits and knowledge gain from e-learning: the longitudinal use of an online learning experience at an international medical school
Zavala-Cerna MG. et al, (2025), BMC Medical Education, 25
Polygenic prediction of coronary heart disease among 130,000 Mexican adults.
Liu T. et al, (2025), Eur J Prev Cardiol
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis.
Neuen BL. et al, (2025), JAMA
88: Renal tubular disorders
TURNER M. and BULL K., (2025), Acute Medicine A Practical Guide to the Management of Medical Emergencies
Effects Of Empagliflozin On Kidney And Cardiac Magnetic Resonance Imaging Measures In Patients With Chronic Kidney Disease: An EMPA-KIDNEY Mechanistic Substudy
ZHU D. et al, (2025), American Journal of Kidney Diseases
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition.
Malijan GB. et al, (2025), Kidney Int Rep, 10, 4090 - 4093
Temporal trends in hospital-recorded pulmonary embolism in England before, during and after the COVID-19 pandemic (2008-2024): a population-based observational study.
Zhong X. et al, (2025), Lancet Reg Health Eur, 58
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Malijan GB. et al, (2025), Am J Kidney Dis
"Hi"s and "Lo"s of Targeting Serum Phosphate Levels in Hemodialysis.
Mayne KJ. and Herrington WG., (2025), J Am Soc Nephrol
Ethics of Antibiotic Course Duration: Shorter is Better
Johnson T. et al, (2025), American Journal of Bioethics
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.
Herrington WG. et al, (2025), Lancet Diabetes Endocrinol
Maternal and Infant Outcomes for Women Experiencing Homelessness Before and During Pregnancy: A Retrospective Cohort Study.
Geddes-Barton D. et al, (2025), BJOG